Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Atara Biotherapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 125 | 118 | −7 |
| Shares | 102.7M | 90.5M | −12.2M (−11.9%) |
| Value | $297.8M | $145.8M | −$152.0M (−51.0%) |
New holders (22)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 683 Capital Management, LLC | 1,000,000 | $1.61M | 0.16% |
| Acadian Asset Management LLC | 704,694 | $1.13M | 0.00% |
| HRT Financial LP | 161,929 | $260.0K | 0.00% |
| XTX Topco Ltd | 136,841 | $220.3K | 0.04% |
| Healthcare of Ontario Pension Plan Trust Fund | 121,000 | $194.8K | 0.00% |
| Cornercap Investment Counsel Inc | 116,159 | $187.0K | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 99,685 | $160.5K | 0.02% |
| Graham Capital Management, L.P. | 85,672 | $137.9K | 0.00% |
| Private Advisor Group, LLC | 62,400 | $100.5K | 0.00% |
| Marshall Wace, LLP | 62,180 | $100.1K | 0.00% |
| Harbor Capital Advisors, Inc. | 50,076 | $80.6K | 0.02% |
| Qube Research & Technologies Ltd | 34,908 | $56.2K | 0.00% |
| JustInvest LLC | 31,423 | $50.6K | 0.00% |
| Centiva Capital, LP | 29,143 | $46.9K | 0.00% |
| Point72 Middle East FZE | 25,351 | $40.8K | 0.00% |
| Ergoteles LLC | 20,326 | $32.7K | 0.00% |
| Pitcairn Co | 19,363 | $31.2K | 0.00% |
| Two Sigma Investments, LP | 15,261 | $24.6K | 0.00% |
| Belvedere Trading LLC | 12,913 | $20.8K | 0.01% |
| Virtu Financial LLC | 12,250 | $20.0K | 0.00% |
| Quantbot Technologies LP | 3,900 | $6.28K | 0.00% |
| Cary Street Partner Investment Advisory LLC | 66 | $106 | 0.00% |
Sold out (29)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.